KELOWNA, BC, Feb. 20, 2020 /CNW/ - Valens GroWorks
Corp. (TSXV: VLNS) (OTCQX: VLNCF) (the "Company",
"Valens" or "The Valens Company"), a global leader in
the end-to-end development and manufacturing of innovative,
cannabinoid-based products, is pleased to announce it expects
to issue its fourth quarter and fiscal year 2019 financial results,
for the period ended November 30,
2019, on Monday, February 24,
2020, after markets close.
CONFERENCE CALL DETAILS
The Company expects to host a conference call the following day,
Tuesday, February 25, 2020, at
11:00 am Eastern Time / 8:00 am Pacific Time to discuss the financial
results and business outlook.
Participant Dial-In Numbers:
Toll-Free: 1-877-407-0792
Toll / International: 1-201-689-8263
*Participants should request The Valens Company Earnings Call or
provide confirmation code 13698760
The call will be webcast on the Valens Investor page of the
Company website at https://thevalenscompany.com/investors/ or
at this link. Please visit the website at least 15 minutes prior to
the call to register, download, and install any necessary audio
software. A replay of the call will be available on the Valens
Investor page approximately two hours after the conference call has
ended.
Tyler Robson, Chief Executive
Officer, Chris Buysen, Chief
Financial Officer, Jeffrey Fallows,
President, and Everett Knight,
Executive Vice President of Corporate Development and Capital
Markets, will be conducting a question and answer session following
the prepared remarks.
About The Valens Company
The Valens Company is a global leader in the end-to-end
development and manufacturing of innovative, cannabinoid-based
products. The Company is focused on being the partner of choice for
leading Canadian and international cannabis brands by providing
best-in-class, proprietary services including CO2, ethanol,
hydrocarbon, solvent-less and terpene extraction, analytical
testing, formulation and white label product development and
manufacturing. Valens is the largest third-party extraction
company in Canada with an annual
capacity of 425,000 kg of dried cannabis and hemp biomass at our
purpose-built facility in Kelowna,
British Columbia which is in the process of becoming
European Union (EU) Good Manufacturing Practices (GMP)
compliant. The Valens Company currently offers a wide range
of product formats, including tinctures, two-piece caps, soft gels,
oral sprays and vape pens as well as beverages, concentrates,
topicals, edibles, injectables, natural health products and has a
strong pipeline of next generation products in development for
future release. Finally, the Company's wholly-owned
subsidiary Valens Labs is a Health
Canada licensed ISO 17025 accredited cannabis testing lab providing
sector-leading analytical services and has partnered with Thermo
Fisher Scientific to develop a Centre of Excellence in Plant-Based
Science. The Company expects to formally change its name in due
course. For more information, please visit
http://thevalenscompany.com. The Company's investor deck can
be found specifically at
http://thevalenscompany.com/investors/.
Notice regarding Forward Looking Statements
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
The TSXV or other regulatory authority has not reviewed,
approved or disapproved the contents of this press release. We seek
Safe Harbour.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-valens-company-to-hold-conference-call-to-discuss-financial-results-for-the-fourth-quarter-and-fiscal-year-2019-301008790.html
SOURCE The Valens Company